OpenAI Launches GPT-Rosalind, a Frontier Model Purpose-Built for Biology and Drug Discovery
A new domain-specific reasoning model targets translational medicine and biological research, signaling OpenAI's push into vertical AI products.
Subscribe to unlock all stories
Get full access to The Singularity Ledger, archive included.
Cancel anytime. Payments powered by Stripe.